Insulet trims FY 2026 revenue growth outlook to 20%-22% constant currency
PODD•FY 2026 guidance cut
Insulet narrowed FY 2026 total revenue growth guidance to 20%-22% on a constant-currency basis, down from 21%-23%.
Total Omnipod growth outlook was cut to 21%-23% from 22%-24%. U.S. Omnipod was trimmed to 17%-19% from 20%-22%.
International outlook raised and Q3 guidance set
International Omnipod forecast was raised to 30%-32% from 26%-28% on constant currency.
Q3 2026 total revenue growth is expected at 17.5%-19.5%.
Guidance assumes continued Omnipod 5 adoption. U.S. expectations reflect lower utilization and higher attrition than previously expected, especially in T2.
